Devices in Heart Failure: From Mechanisms to Implementation
Meeting Summary (Need and Overview)
This new HFSA offering will focus on the role of devices in heart failure. The full day meeting will include didactic sessions, access to two unique hands-on sessions, an exhibit hall of device vendors, and time to network. Topics include the current state of devices in HF and where they are heading, the rise of device-based therapies in HF and direction of new career paths, current decongestion strategies and the role of diuretics, the rebirth of hemodynamics in cardiology and the role of HF physicians, remote patient care, cross-silo collaboration and panel discussion on the roles of interventional and electrophysiology, and new frontiers for innovation in HF (focused on HFpEF, infiltrative cardiomyopathies and genetics). The hands-on sessions will include cardiac catheterization, left ventricular assist devices and temporary mechanical circulatory devices. There will be two sessions focused on device companies that are running a trial and looking for sites or companies about to launch into a trial, and for device companies with established trials in process.
Learning Objectives
Following this activity, participants will be better able to:
- Discuss the current landscape of devices in heart failure treatment, including emerging trends and future possibilities.
- Utilize practical experience in device handling, operation, and implementation by rotating through two hands-on sessions in cardiac catheterization laboratory, LVAD, and temporary MCS
- Appraise the limitations and potential benefits of traditional diuretic therapies in comparison to newer, innovative decongestion therapies
- Understand the resurgence of hemodynamic monitoring in heart failure care, including advanced diagnostic tools and therapeutic strategies aimed at optimizing cardiac function.
- Evaluate the role of remote patient monitoring and telemedicine in the management of heart failure, focusing on their impact on patient outcomes, healthcare efficiency, and interdisciplinary collaboration.
- Discuss challenges and opportunities associated with integrating remote care solutions into routine heart failure management, and how remote care has changed over time
- List novel devices and trials entering testing for heart failure treatment
Faculty
Faculty
Lead and Faculty Chair
Marat Fudim (chair)
Jennifer Cowger
Hima Vidula
Liviu Klein
Hands-On Session Faculty
Cath lab:
Marat Fudim
Jackie DesJardin
Mark Kittipibul
LVAD:
Hima Vidula
Farooq Skeikh
Iyad Isseh
Temp MCS:
Jennifer Cowger
Rebecca Cogswell
Alexander Hajduczok
Other Faculty and Panelists:
JoAnn Lindenfeld
Mark Belkin
Daniel Bensimhon
Jan Biegus
Javed Butler
Johanna Contreras
Michael Felker
Richa Gupta
Shelley Hall
Nadira Hamid
Liviu Klein
Anu Lala
Carolyn Lam
Robert Mentz
Piotr Ponikowski
Mitch Psotka
Andrew Sauer
Ryan Tedford
Nir Uriel
Dmitry Yaranov
Daniel Burkhoff
Sitaresh Emani
Jason Guichard
Ulrich Jorde
Rami Kahwash
Nancy Sweitzer
Heart Tank/Trial Tinder presenters:
Trial Tinder:
Sanjeev Gulati
Andrew Sauer,
James Udelson
Glora Weisz
Marat Fudim
Lee Goldberg
RIshi Puri
Carolyn Lam
John Martin
Heart Tank:
Steve Pham
Suresh Gurunathan
Leonhard Riehle
William Abraham
Marat Fudim
John Brumsfield
Agenda
Welcome & Introductions
Where is the Profession of Heart Failure Headed?
Moderator
Marat Fudim,MD
Panelists:
Liviu Klein, Andrew Sauer, Shelley Hall, Jennifer Cowger, Himavindu Vidula, Marat Fudim, Ryan Tedford
The Rise of Device-Based Therapies in Heart Failure -- NEw Career Paths in Heart Failure
Moderator:
JoAnn Lindenfeld, MD
Panelists:
Liviu Klein, Andrew Sauer, Shelley Hall, Jennifer Cowger, Himavindu Vidula, Marat Fudim, Ryan Tedford
Decongestion Strategies in the 21st Century. Are we still just pushing diuretics?
Moderator:
Ulrich Jorde, MD
Panelists:
Liviu Klein, Andrew Sauer, Shelley Hall, Jennifer Cowger, Himavindu Vidula, Marat Fudim, Ryan Tedford
Hands-On Sessions
Cardiac Catheterization Laboratory Hands On Session
Cath Laboratory: Marat Fudim, MD, Jacqueline DesJardin, MD, Mark Kittipibul, MD
LVAD Hands-On Session
Himavindu Vidula, MD, MS, Farooq Skeikh, MD, Iyad Isseh, MD
Temporary MCS Hands-On Session
Temp MCS: Jennifer Cowger, MD, MS, Rola Khedraki, MD, Alexander Hajduczok, MD
Rebirth of Hemodynamics in Cardiology! Where does the Heart Failure Doc Fit in?
Moderator:
Daniel Burkhoff
Panelists:
Dmitry Yaranov, Mark Belkin, Richa Gupta, Nir Uriel, Johanna Contreras
The Evolution of Clinical Care In Heart Failure: Beyond the Walls of the HOspital - Remote Patient Care
Moderator:
Jason Guichard
Panelists:
Dmitry Yaranov, Mark Belkin, Richa Gupta, Nir Uriel, Johanna Contreras
Cross-Silo Collaboration - Where Does Interventioal Fit in
Moderator:
Sitaresh Emani
Panelists (Cardiac Catheterization Laboratory Hands On Session):
Sitaresh Emani, Nadira Hamid, Michael Felker, Daniel Bensimhon, Carolyn Lam, Jan Biegus, Rami Kahwash
Cross-Silo Collaboration - Where Does Electrophysiology Fit in (LVAD Hands-On Session & Temporary MCS Hands-On Session)
Moderator:
Rami Kahwash
Panelists:
Dmitry Yaranov, Mark Belkin, Richa Gupta, Nir Uriel, Johanna Contreras
Trial Tinder: Choose My Trial! Acute HF Edition
Panelists:
Mitchell Psotka, Robert Mentz, Anu Lala, Miguel Alvarez, Marat Fudim, Javed Butler, Piotr Ponikowski
Trial Tinder: Choose My Trial! Chronic HF Edition
New Frontiers for Innovation in Heart Failure - HFpEF, Infiltrative Cardiomyopathies and Genetics
Moderator:
Nancy Sweitzer
Panelists:
Mitchell Psotka, Robert Mentz, Anu Lala, Miguel Alvarez, Marat Fudim, Javed Butler, Piotr Ponikowski
Heart Tank - The Future in the Making
Closing Session: Reception - Vendor Demonstrations
Accreditation Statement
In support of improving patient care, The Heart Failure Society of America is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The Heart Failure Society of America designates this activity for a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This educational activity is approved for Nursing Continuing Professional Development (NCPD) units by the Heart Failure Society of America. This activity is approved for a maximum of 4.25 contact hours. Nurses should claim only the credit commensurate with the extend of their participation in the activity.
The Heart Failure Society of America has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 4.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Important Date
This educational content was produced
Friday, September 26, 2025
8:30 am - 5:30 pm